APA (7th ed.) Citation

Morè, S., Manieri, V. M., Corvatta, L., Morsia, E., Rupoli, S., Olivieri, A., & Offidani, M. (2022). P25: CARFILZOMIB-BASED TREATMENTS COULD BE ADDED TO IMPEDE-VTE SCORE TO BETTER PREDICT VENOUS THROMBOEMBOLIC RISK IN MM PATIENTS. Wiley.

Chicago Style (17th ed.) Citation

Morè, S., V M. Manieri, L. Corvatta, E. Morsia, S. Rupoli, A. Olivieri, and M. Offidani. P25: CARFILZOMIB-BASED TREATMENTS COULD BE ADDED TO IMPEDE-VTE SCORE TO BETTER PREDICT VENOUS THROMBOEMBOLIC RISK IN MM PATIENTS. Wiley, 2022.

MLA (9th ed.) Citation

Morè, S., et al. P25: CARFILZOMIB-BASED TREATMENTS COULD BE ADDED TO IMPEDE-VTE SCORE TO BETTER PREDICT VENOUS THROMBOEMBOLIC RISK IN MM PATIENTS. Wiley, 2022.